Request:  A global pharmaceutical sponsor conducting a Phase III clinical trial required Semaglutide, a GLP-1 receptor agonist, as a...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

At Clinical Services International (CSI), we continually strive to exceed the expectations of our pharmaceutical and biotech partners by...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Here is a success story that demonstrates how CSI can support your clinical trial supplies. CSI managed to compress six months of...

Innovation in oncology drug development is granting cancer patients access to life-changing therapies. The industry continues to conduct...

How CSI’s scientific insight delivered an agile sourcing model and substantial cost savings for a listed biotechnology company’s global...

Unwrap CSI's Twelve Case Studies of Christmas 2020 has been a challenging year, with product shortages, borders closing, more...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more...

Webinar: How to identify and manage risks in clinical trial supplies and comparator sourcing CSI hosted a webinar with Xtalks on Monday...